Behçet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12544532.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Behçet's disease is a chronic inflammatory disease characterized by recurrent oral aphthae and systemic manifestations. Gastrointestinal involvement is rare. We report a case of ileocolitis secondary to Behçet's successfully treated with tumor necrosis factor-alpha antibody (infliximab) therapy. To our knowledge this is the second reported case of Behçet's ileocolitis successfully treated with anti-tumor necrosis factor therapy.
Medical subject headings
- Antibodies, Monoclonal
- Behcet Syndrome
- Colitis
- Gastrointestinal Agents
- Ileitis
- Tumor Necrosis Factor-alpha